Hidden Cost Of Mergers? JAMA Editorial Says Never Stop Trials Due To Cost
Executive Summary
Pharma companies need to consider an obligation to complete ongoing clinical trials when entering into merger agreements, an editorial published in The Journal of the American Medical Association argues
You may also be interested in...
ClinicalTrials.Gov Registry Needs Legislative Boost, JAMA Editorial Says
Congress needs to add funding and enforcement tools to the legislation creating the ClinicalTrials.gov clinical trials registry, a "special communication" in the July 23/30 issue of the Journal of the American Medical Association says
ClinicalTrials.Gov Registry Needs Legislative Boost, JAMA Editorial Says
Congress needs to add funding and enforcement tools to the legislation creating the ClinicalTrials.gov clinical trials registry, a "special communication" in the July 23/30 issue of the Journal of the American Medical Association says
ALLHAT Supports First-Line Norvasc Use, Pfizer Claims
Pfizer plans to use the ALLHAT clinical study results to promote the calcium channel blocker Norvasc (amlodipine) in 2003